Displaying 37 - 48 of 65
Immune-Mediated and Cholestatic Diseases
4

Intercept: PBC Through the Years: Time to Move Ahead - ILC 2022

View
Immune-Mediated and Cholestatic Diseases
4

Intercept: PBC Through the Years: Time to Move Ahead - ILC 2022

View
Immune-Mediated and Cholestatic Diseases
4

Intercept: PBC Through the Years: Time to Move Ahead - ILC 2022

View
General Hepatology
4

Mirum: Patient, caregiver, and physician: Understanding perspectives in adult and paediatric cholestasis - ILC 2022

View
General Hepatology
4

Mirum: Patient, caregiver, and physician: Understanding perspectives in adult and paediatric cholestasis - ILC 2022

View
General Hepatology
4

Mirum: Patient, caregiver, and physician: Understanding perspectives in adult and paediatric cholestasis - ILC 2022

View
Immune-Mediated and Cholestatic Diseases
4

Albireo Pharma: Idiopathic Cholestasis and Targeted Next-Generation Sequencing Panels: A Case-Based Approach - ILC 2022

View
Immune-Mediated and Cholestatic Diseases
4

Albireo Pharma: Idiopathic Cholestasis and Targeted Next-Generation Sequencing Panels: A Case-Based Approach - ILC 2022

View
Immune-Mediated and Cholestatic Diseases
4

Albireo Pharma: Idiopathic Cholestasis and Targeted Next-Generation Sequencing Panels: A Case-Based Approach - ILC 2022

View
General Hepatology
4

Mirum: Patient, caregiver, and physician: Understanding perspectives in adult and paediatric cholestasis - ILC 2022

View
Metabolism, Alcohol & Toxicity
6

Perspectum: Advances in non-invasive imaging for NAFLD / NASH - ILC 2022

View
Viral Hepatitis
6

AbbVie: An HCV-Free Future - It Always Seems Impossible Until It's Done - ILC 2022

View
Displaying 37 - 48 of 65